St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods
Authors
Keywords
Ki67, Proliferation, Breast cancer, St Gallen consensus, Intrinsic subtyping, Methodology
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 159, Issue 2, Pages 257-263
Publisher
Springer Nature
Online
2016-08-24
DOI
10.1007/s10549-016-3950-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines – a Swedish survey with central re-assessment
- (2015) Maria Ekholm et al. ACTA ONCOLOGICA
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Strategies for developing Ki67 as a useful biomarker in breast cancer
- (2015) Carsten Denkert et al. BREAST
- The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer
- (2015) Matthias Christgen et al. HUMAN PATHOLOGY
- Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility
- (2015) Akira I Hida et al. JOURNAL OF CLINICAL PATHOLOGY
- An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer
- (2015) Ruohong Shui et al. PLoS One
- Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
- (2015) Zsuzsanna Varga et al. PLoS One
- Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study
- (2014) F. Klauschen et al. CLINICAL CANCER RESEARCH
- A novel model for Ki67 assessment in breast cancer
- (2014) Quinci Romero et al. Diagnostic Pathology
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information
- (2013) Linda P Feeley et al. MODERN PATHOLOGY
- Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse
- (2012) G. Cancello et al. ANNALS OF ONCOLOGY
- Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
- (2012) S. Guiu et al. ANNALS OF ONCOLOGY
- Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer
- (2012) Einar Gudlaugsson et al. HISTOPATHOLOGY
- Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
- (2012) Aleix Prat et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Classification of Estrogen Receptor-positive/Luminal Breast Cancers
- (2011) Felipe C. Geyer et al. ADVANCES IN ANATOMIC PATHOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
- (2011) Elisabeth Luporsi et al. BREAST CANCER RESEARCH AND TREATMENT
- Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
- (2011) S Fasanella et al. Diagnostic Pathology
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers
- (2008) Jan P. A. Baak et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More